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ABSTRACT
6PDOOLQWHVWLQDOEDFWHULDORYHUJURZWK6,%2LVDFOLQLFDOFRQGLWLRQLQZKLFKH[FHVVDPRXQWVRIEDFWHULDDUH
IRXQGLQVPDOOLQWHVWLQH6,%2RFFXUUHGZKHQQRUPDOKRPHRVWDWLFPHFKDQLVPZKLFKFRQWUROHQWHULFEDFWHULD
SRSXODWLRQGLVUXSWHG(OGHUO\SDWLHQWVDUHPRUHYXOQHUDEOHWR6,%2ZKLFKFDQEHFDXVHGE\WZRFRQGLWLRQV
which are gastric acid reduction and disproportionately drugs consumption which then caused hypomotility. 
7KHUHDUHVHYHUDOPHWKRGVWRGLDJQRVH6,%2EXWGLDJQRVHRIWHQEHJLQZLWKVXVSLFLRQDQGKLVWRU\RIULVNIDFWRUV
RI6,%27KHUHDUHWZRPRVWIUHTXHQWWHVWVLQ6,%2GLDJQRVWLFZKLFKDUHEDFWHULDOFXOWXUHH[DPLQDWLRQDQG
EUHDWKWHVW7UHDWPHQWVRI6,%2DUH7UHDWPHQWRIXQGHUO\LQJGLVHDVHDQGLPSURYHPHQWRIPHGLFDOFRQGLWLRQ
(UDGLFDWLRQRIH[FHVVEDFWHULDOJURZWK5HVROYHQXWULWLRQDOGH¿FLHQFLHVZKLFKUHODWHGWR6,%2
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ABSTRAK
6PDOOLQWHVWLQDOEDFWHULDORYHUJURZWK6,%2DWDXSHUWXPEXKDQEDNWHULEHUOHELKDQGLXVXVKDOXVDGDODK
VXDWXNRQGLVLNOLQLNGLPDQDWHUGDSDWEDNWHULGDODPMXPODK\DQJEHUOHELKDQGLXVXVKDOXV6,%2WHUMDGLNHWLND
mekanisme homeostatis normal yang mengontrol populasi bakteri enterik terganggu. Pasien berusia lanjut 
OHELKUHQWDQPHQJDODPL6,%2\DQJGDSDWGLVHEDENDQROHKGXDNHDGDDQ\DLWXSHQJXUDQJDQDVDPODPEXQJ
dan konsumsi obat-obat secara tidak proporsional yang kemudian menyebabkan hipomotilitas. Ada beberapa 
FDUDXQWXNPHQHJDNNDQGLDJQRVLV6,%2QDPXQGLDJQRVLVVHULQJGLPXODLGHQJDQNHFXULJDDQGDQULZD\DWIDNWRU
ULVLNR6,%27HUGDSDWGXDPDFDPSHPHULNVDDQ\DQJSDOLQJVHULQJGLODNXNDQGDODPSHQHJDNDQGLDJQRVLV6,%2
\DLWXSHPHULNVDDQNXOWXUEDNWHULGDQEUHDWKWHVW7DWDODNVDQD6,%2DQDWDUDODLQ3HQJREDWDQSHQ\DNLWGDVDU
GDQSHUEDLNDQNRQGLVLHUDGLNDVLSHUWXPEXKDQEDNWHUL\DQJEHUOHELKDQPHQJDWDVLGH¿VLHQVLQXWULVL
\DQJEHUNDLWDQGHQJDQ6,%2
Kata kunci: small intestinal bacterial growth, diagnosis, tatalaksana
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INTRODUCTION
Small intestinal bacterial overgrowth (SIBO) is a 
clinical condition, in which excess amount of bacteria 
are found in small intestine.1 Pathogenesis of this disease 
VWLOOQRWIXOO\XQGHUVWRRG\HW$W¿UVWWKLVGLVHDVHRQO\
occurred in small numbers of patients, however it was 
estimated to occurred in more patients. Patients with 
SIBO have various clinical manifestations, from mild 
symptoms to severe symptoms like severe diarrhea, 
weight loss, and malabsorption.1 Several tests are 
already available for diagnosis of SIBO, although 
RSWLPDOUHJLPHQWWUHDWPHQWVWLOOGLI¿FXOWWRH[SODLQHG
Nowadays, there is growing interest in SIBO 
researches. Currently, research showed that SIBO is 
important factor in pathophysiology mechanism of 
irritable bowel syndrome (IBS), with prevalence 38% 
to 48% in IBS patients.7 SIBO is a clinical condition 
which caused by abnormal numbers of bacteria in 
small intestine, with different predisposing factors, like 
motility disorders and disruption in gastric acid barrier.7
Patients with SIBO often manifests as chronic 
diarrhea, weight loss, malabsorption, nutritional 
deficiencies, and osteoporosis.1 Most frequent 
misconception is SIBO only affects small numbers 
of patients, which are patients with anatomical 
abnormality in upper gastrointestinal tract or patients 
with motility disorder.1 However, SIBO proven to be 
occur in wider population than previously estimated, 
which proven through various diagnostic tests which 
increase the clinical capabilities in SIBO diagnosis.4 
DEFINITION OF SMALL INTESTINAL BACTERIAL 
OVERGROWTH (SIBO)
6,%2GH¿QHGDVDFOLQLFDOFRQGLWLRQZKHQEDFWHULD
population in small intesetine found to be more 105-106 
organism/mL.1,2 In normal condition, it found less than 
103 organisme/mL on upper region of small intestine 
which mostly are gram positive organisms.2,3 Beside the 
DEVROXWHDPPRXQWRIRUJDQLVPW\SHRIPLFURELDOÀRUD
decide manifestation of signs and clinical symptoms of 
SIBO.1 Characteristic things about SIBO are the excess 
aerob and anaerob bacteria which colonized small 
intestine, which an area where bacteria population 
is plentiful.4%DFWHULDZKLFK NQRZQ VSHVL¿FDOO\ DV
SIBO especially are colon type bacteria and therefore 
consist mostly of gram negative aerob bacteria and 
anaerob bacteria which feremented carbohidrate to gas. 
4 Bacteria which usually found as SIBO are Escherichia 
coli, Enterococcus spp, klebsiella pneumonia, Proteus 
mirabils, and others.4 Hypothesis which proposed 
about SIBO are expansion of bacteria from colon to 
small intestine which causing symptoms like fullness 
sensation, uncomfertable feeling in stomach and 
alteration in stool consistency.4 
RISK FACTORS OF SMALL INTESTINAL 
BACTERIAL OVERGROWTH (SIBO)
SIBO can develop in vatious population with risk 
factors. Several risk factors in the development of 
SIBO are: (1) Structural/anatomic: small intestine 
diverticulosis; small intestine strictur (radiation, 
medication, Crohn’s disease); surgically created 
blind loops; ileiocecal valve resection; fistula 
between proximal and distal area of intestine; gastric 
resection; (2) Motility disorder: gastroparesis; small 
intestine dismotility; celiac disease; chronic intestine 
pseudo-obstruction; (3) Irritable bowel syndrome: 
in a study by Pimental et al, it was found that 78% 
of 202 patients who meet Rome I criteria for IBS 
diagnosis have abnormalities in lactulose breath test 
results which supported SIBO diagnosis. Extended 
gastric emptying, motility disorder, migrating motor 
complex disorder, which all of them happened in 
IBS become predisposition of SIBO1; (4) Metabolic 
disease: long and uncontrolled diabetes mellitus can 
impair gastrointestinal nervous system which then 
cause gastrointestinal motility disorder. Diabetic 
gastroparesis and neuropatic intestinal motility are 
related to SIBO. Current researches shown that SIBO 
found in 43% diabetic patients with chronic diarrhea, 
DQGRIWKHPKDYHVLJQL¿FDQWLPSURYHPHQWDIWHU
treatment with antibiotic1; (5) Elderly patients: Mitsui 
et al with glucose breath test found that 33% elderly 
patients with disability have SIBO; (6) Disfunction of 
organ systems: cirrhosis; kidney failure; pancreatitis; 
LPXQRGH¿FLHQF\FRQGLWLRQV&URKQ¶VGLVHDVH&HOLDF
disease; malnutrition; (7) Medication: recurrent use 
of antibiotics; gastric acid suppression; (8) Chronic 
diarrhea.1-4
PATHOGENESIS OF SMALL INTESTINAL 
BACTERIAL OVERGROWTH (SIBO)
SIBO occurred when normal homeostatic 
mechanism which control enteric bacteria population 
disrupted. Two most common processes which become 
predisposition of excess bacteria growth in small 
intestine are: decrease or loss of gastric acid secretion 
and small intestinal dismotility. Disorder in intestinal 
immune function and instestinal anatomic abnormality 
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also increase the possibility of SIBO. Then, SIBO will 
WULJJHUDQLQÀDPPDWRU\UHVSRQVHLQLQWHVWLQDOPXFRVH
which in turn will trigger exacerbation of clinical 
symptoms of SIBO. Although often unobserved, 
excess growth of bacteria in intestine can cause 
PLFURVFRSLFDO LQÀDPDWLRQ LQPXFRVH$QDO\VLV RI
small intestine biopsy in elderly patients with SIBO 
showed dull intestinal villi, thinning of intestinal 
mucous and crypts, and increase in the intraepithelial 
lymphocytes, which all of them can back to normal 
with administering antibiotic.1,4
Gastric Acid
Gastric acid suppress bacterial growth, thus 
limiting numbers of bacteria in upper region of small 
intestine.1,4,7 Loss of gastric acid (hypochlorhydria) is 
SIBO risk factor, and can occurred after Helicobacter 
pylori colonization, or as consequence of aging 
proccess. Excess bacterial growth can caused false 
positive result in H. pylori diagnosis with urea-based 
test which shown presence of urease-positive bacteria 
strain. Inhibition to gastric acid secretion is through 
histamine type 2 receptor antagonist (H2RAs) or 
proton pump inhibitor can caused SIBO, although some 
studies still showed controversial results.1 
Treatment with H2RA which caused SIBO in 
18 patients are measured by bile acid breathtest 
and jejenum aspiration. In a prospective study, 47 
outpatients which treated with omeprazol 20 mg/
day or cimetidine 800 mg/day shown that excess 
bacterial growth can be found on 53% which treated 
with omeprazol, compared to 17% which treated with 
cimetidine (p < 0.5). Twenty patients which treated 
ZLWKRPHSUD]RO IRUZHHNVH[SHULHQFHGVLJQL¿FDQW
increase in number of bacteria in duodenum, compared 
baseline population which measured with endoscopic 
aspiration.4
Gastrointestinal Dismotility
Several research shown that abnormality in 
migrating motor complex can be SIBO predisposition. 
Duting fasting, migrating motor complex arise every 
90–120 minute to moving the food digestion residual 
in gastrointestinal system. Gastroparesis is a chronic 
disorder in form of gastric emptying disorder, which 
could arise because of long uncontrolled diabetes, 
connective tissue disorder, previous viral infections, 
and ischemia. Impaired intestinal peristalsis can 
caused SIBO because of food statis and bacteria in 
gastrointestinal upper region.1
Small intestine motility disorder can also become 
SIBO predisposition, because the bacteria was not 
effectively removed from proximal intestine into 
colon. Patients with cirrhosis and portal hypertension 
(compared with patients without portal hypertension) 
have retrograde pressure wave in proximal duodenum, 
grouped contraction, and abnormality of migrating 
motor complex which increase the SIBO prevalence. 
Patients with chronic renal impairment have 
neuropathic-like motor abnormality in small intestine 
and have tendency to caused SIBO. Neuropathic 
process as chronic pseudo-obstruction intestinal (CIP), 
and myopathic process, such as scleroderma and 
polymyositis have tendencies to relate with SIBO. In 
the small group of patients with systemic sclerosis with 
over 105 CFU/μL by duodenal aspiration, 7 out of 8 
patients have positive results in lactulose breath test.1
Gastrointestinal Structural Abnormality
Gastointestinal structural abnormality is an ideal 
environment for bacteria colonization and SIBO 
development. Gastrointestinal surgery which formed 
blind loop (Billroth II or Roux-en Y anastomosis 
procedure) is a predisposition bacterial static and 
SIBO development because of motility disorder and 
uneffective gastrointestinal clearance. Patients who 
undergone jejunoileal bypass, end-to-side enteroenteric 
anastomosis, or Koch distal ileal pouch forming 
procedure also risked to develop SIBO.1
Small intestine divertikulosis also happened in 
almost 1% – 6% population based on autopsion and 
various radiography research. This disorder commonly 
incidental, asymptomatic, and small sized. However, 
large duodenum or jejenum divertikulosis can trigger 
SIBO development. Small intestine strictur which 
can formed after surgery or after radiation procedure 
in Crohn’s disease can trigger SIBO development.1 
Ileocecal valve resection also increase the risk of SIBO 
development because enabled retrograde motion of 
bacteria from colon into small intestine. A research 
with Crohn’s patients showed that ileocecal valve 
UHVHFWLRQVLJQL¿FDQWO\LQFUHDVH6,%2SUHYDOHQFHIURP
18% to 30%.1
Immune Function
Patients with immunodeficiency because of 
antibody response abnormality or T cell response have 
susceptibility to SIBO. Patients with SIBO compared 
to patients with patients with normal jejunal aspiration 
have tendencies to have imunnity disorder in intestinal 
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mucous, which proved with increased concentration 
of luminal immunoglobulin A (IgA) and number of 
plasma IgA cell in lamina propria. Patients with cellular 
DQG KXPRUDO LPPXQRGH¿FLHQF\ QRW SUHGLVSRVHG WR
SIBO development because they have normal intestinal 
PLFURÀRUD1
PREVALENCE OF SMALL INTESTINAL BACTERIAL 
OVERGROWTH (SIBO)
Prevalence of SIBO and its correlation with several 
GLVRUGHUVDUHQRWNQRZQ\HWEHFDXVHRIGLI¿FXOW\ LQ
UHVHDUFKDQGGH¿QLWLRQ7KHGLI¿FXOW\LQGHWHUPLQHWKH
true prevalence of SIBO is because of correlation of 
SIBO with several disease and many symptoms often 
overlaping between them. Characteristic thing about 
SIBO is presence of excessive amounts of aerobic 
bacteria. Several patients often did not come to physician 
to be treated so that SIBO often undiagnosed. Small 
intestinal bacterial overgrowth could be asymptomatic or 
DSSHDUZLWKXQVSHFL¿FFOLQLFDOV\PSWRPV)XWKHUPRUH
prevalence of SIBO depend on characteristic of the 
study population and diagnostic methods used to 
diagnose SIBO. If breath test used as diagnostic method, 
prevalence will varied depend on the nature and dosage 
of the substrate being used.4 
In healthy people, SIBO found in 0-12,5% with 
glucose breath test, 20-22% with lactose breath test, 
dan 0-35% with 14C D-xylose breath test. Elderly patient 
are more vulnerable to SIBO which can be caused by 
two conditions, which are gastric acid reduction and 
disproportionately drugs consumption which then 
caused hypomotility.4 Prevalence of SIBO in IBS 
patients varied from 30% to 85% according the source 
being used. Prevalence of SIBO in hepatic cirrhosis is 
around 50%, whereas in celiac disease prevalence of 
SIBO in several studies is around 50%. Prevalence of 
SIBO in asymptomatic obese patients is around 17%.4
CLINICAL MANIFESTATIONS OF SMALL 
INTESTINAL BACTERIAL OVERGROWTH (SIBO)
Although the clinical symptoms of SIBO can be 
known clearly, there are several studies which aim 
to determine typical clinical symptoms of SIBO. 
Clinical symptoms of SIBO normally covered by 
clinical symptoms of the underlying diseases, such 
as scleroderma. Clinical manifestations of SIBO 
are depend on severity of the diseaset. In Billroth II 
subjects, when the number of coliform > 1 x 105 cfu/
P/SDWLHQWZLOOH[SHULHQFHVLJQL¿FDQWPDODEVRUSWLRQ
as well as the typical symptom of bloating, but it 
is unclear whether these symptoms are caused by 
surgery, ammount of intestine bacteria, or because 
of another consequences. But now, it was believed 
that most patients with SIBO not experienced 
clinical malnutrition due to malabsorption. In 
this case, unspecific clinical symptoms include 
GLVWHQVLRQÀDWXOHQFHDQGGLDUUKHD2QO\VHYHUDOUDUH
conditions such as jejunoileal bypass operation or short 
bowel syndrome which caused vitamin and mineral 
GH¿FLHQFLHV LQFOXGLQJ IDWVROXEOH YLWDPLQV VXFK DV
vitamin A, vitamin D, vitamin B12 and iron.
Recent researches showed that SIBO correlated 
to IBS and excess bacterial growth is part of IBS 
pathogenesis.7,8 SIBO is also reported have clinical 
manifestation rosacea, which is a clinical condition in 
skin face.4 D-Lactic acidosis is a severe complicationof 
short bowel syndrome (with intact colon). This 
condition is caused by excess growth of Lactobacillus. 
This condition can be accompanied by neurological 
abnormalities like confusion, cerebelar ataxia, speech 
disorder, memory loss, and consciousness impairtment.4 
7DEOH6WHSVRI6,%2,GHQWL¿FDWLRQLQSDWLHQW
Test type
Physical examination 1RQVSHFL¿F ¿QGLQJV DEGRPHQ
distension, small intestinal 
succession splash (Taylor et al, 
1991), connective tissue related 
to previous surgery, severe 
cases which can caused latent 
tetany, polyneuropathy, dan skin 
manifestastion (rosacea)
Laboratory test Anemia, low level of vitamin 
B12, malnutrition clinical signs 
(limfopenia, low level of serum pre-
albumin dan transferrin, increased 
level of serum folic dan vitamin K 
(produced by bacteria)
Direct examination Quantitative culture of luminal 
contents
Indirect examination Breath test: 14C d-xylose, hydrogen
Other diagnostic tests Urine tests, Serum tests
radiology/colonoscopy Barium test, CT enterography to 
determine mechanical cause of 
small intestinal bacterial overgrowth
DIAGNOSIS OF SMALL INTESTINAL BACTERIAL 
OVERGROWTH (SIBO)
There are several methods to diagnose SIBO, but 
diagnose often begin with suspicion and history of risk 
factors of SIBO. Many sources recommend aspiration 
and direct culture of jejenum as gold standard although 
limitation on diagnostic biopsy tools often make SIBO 
undiagnosed. There is not diagnostic test to diagnose 
SIBO, although SIBO has been known as a clinical 
entity. Physical examination and laboratory test can 
EHXVHGDOWKRXJKWKHUHVXOWVRIWHQQRWVSHFL¿F*ROG
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standard test to diagnose SIBO is quantitative culture 
from jejunum aspirate, with result > 1 x 105 CFU/mL 
liquid. However, this value is not validated yet and 
currently it was thought to be more accurate if the value 
> 1 x 103 based on systematic review.
 There are two most common methods in SIBO 
diagnosis, which are bacteria culture test and breath 
test.4,QEUHDWKWHVWVSHFL¿FDOO\K\GURJHQEUHDWKWHVW
can be done. Non-invasive breath test shown sensitivity 
 DQG VSHFL¿FLW\  DOWKRXJK YDOLGDWLRQV
with culture are still limited.4 Stool test also can be 
used to determine wheter steatorrhea presents or not. 
Futhermore, small intestine barium radiography and 
&7HQWHURJUDSK\FDQEHXVHGWRLGHQWL¿HGPHFKDQLFDO
predisposition factors of intestinal stasis.
Direct Test of Small Intestinal Bacterial Overgrowth 
(SIBO)
Most accepted test to diagnose SIBO is quantitative 
culture of intestinal contents, with value > 1 x 105 
CFU/mL which traditionally perceived as not normal. 
However, recent evidences support argument that this 
value is too much and only represent SIBO in surgery 
patients. Based on normal human small intestine 
FXOWXUH GH¿QLWLRQRI6,%2 LV QXPEHU RI EDFWHULD!
103 CFU/mL. Appropriate culture technique is still not 
well determined. Sterile catheter which through upper 
gastrointestinal endoscopy is a specimen collection 
tool that is free from contamination of saliva and other 
VHFUHWLRQÀXLGV&XOWXUHWHFKQLTXHRQDVSLUDWHVDPSOHV
also varied. Test samples often place in non-selective 
media. The main concern in culture method is the 
GLI¿FXOW\WRDFFHVVGLVWDOUHJLRQRIVPDOOLQWHVWLQH7KLV
test required relatively expensive cost and quite risky, 
EHFDXVHHQGRVFRS\DQGÀXRURVFRS\DUHQHHGHGWRSODFH
aspiration catheter. Limitation of jejunal aspirate are 
only small portion of small intestine bacteria that can be 
culture because of there are 400 to 500 bacteria species 
in intestine, and most of these bacteria is not routinely 
FXOWXUHGDOVRRURIDULQJHDOÀRUDFRQWDPLQDWLRQFDQEH
happened during specimen collection. Beside that, 
bacterial gwoth can be excessive.
Indirect Test of Small Intestinal Bacterial Overgrowth 
(SIBO)
Nowadays, breath test is commonly used as 
alternative test to direct aspiration test because of this 
test is relatively non-invasive dan not expensive. Most 
commonly used breath test is 14C d-xylose breath test 
depend on intestinal bacteria to release absorbed 14C 
CO2 which then eliminated through breath which can 
be counted. Radioactive 14C or stable isotop 13C can 
be used to marked 1 g xylose. According to King and 
Toskes, 14C d-xylose test sensitivity ranged between 
WRDQGVSHFL¿FLW\EHWZHHQWR
However this test not routinely used because of not 
widely available and replaced by hydrogen breath 
test which considered more accurate. Beside that, 
disorder that related to gastic emptying can give false 
negative result, while very fast gastic emptying can 
give false positive which caused by early exposure to 
test substrate in colon.4
Hydrogen breath test based on consideration 
WKDW FDUERK\GUDWH IHUPHQWDWLRQ E\ LQWHVWLQDO ÀRUD
especially anaerob bacteria in colon which is the 
only one hydrogen source in the body. When bacteria 
in colon colonized in small intestine as SIBO, 
carbohidrate fermentation in small intestine produced 
premature hydrogen gas in large ammount. The H2 
which produced by this way difused to systemic 
circulation and excreted from lungs in expirated air. 
+\GURJHQEUHDWK WHVW GRQHKRXUV DIWHU ORZ¿EHU
food consumption in 1 day period. Patient then asked 
to exhale breath to a tube that connected into a bag 
and baseline H2 value obtained before substrate intake 
that will be fermented. Then, carbohidrate substrate 
(glucose, lactulose, dan xylose) given orally and end 
sequential expirated breath done after 15 minutes 
in 3 hours period. Because of relatively cheap and 
easy procedure, hydrogen breath test is the most 
commonly used test to diagnose SIBO, and lactose 
hydrogen breath test is the most commonly used 
hydrogen test. Increased hydrogen level after lactulose 
FRQVXPSWLRQ¿UVWUHSRUWHGE\%RQGDQG/HYLWW4 In this 
FDVH LQWHVWLQDO ÀRUD IHUPHQWHG ODFWXORVH SURGXFHG
hydrogen and or methane. After 10 gram lactulose 
administration, breath samples taken with 15 minutes 
interval 15 menit in 3 hours period.4
Criteria for positive breath test is still problematic 
and not well validated. However, the most commonly 
used technique to determine increased hydrogen more 
than 20 ppm and double pesk in hydrogen breath 
expiration graphic.1 First peak value caused by gas 
that produced by intestinal bacteria which undergo 
excess growth in small intestine. The second cause 
LVFHFDOÀRUDDFWLYLW\$OPRVWDOOUHVHDUFKHUVDVVXPH
that increassed H2 level happened 90 minutes after 
lactulose enter the gastrointestinal system. This breath 
test become chosen test modality to screening and 
treatment monitoring.1
Other tests that useful to diagnose SIBO is 
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UDGLRORJLFDO H[DPLQDWLRQZKLFK XVHIXO WR LGHQWL¿HG
causative factors like jejenum divertikulosis. Biopsy 
in SIBO patients is not effective to diagnose SIBO 
because of wounds in mucous and atrophy of villi only 
happend in patients with severe SIBO. Urinary choly 
p-aminobenzoic acid (choly-PABA) and indicant also 
can be used to diagnose of SIBO.4
TREATMENT OF SMALL INTESTINAL BACTERIAL 
OVERGROWTH (SIBO)
Treatment of SIBO is quite complex and 
individualized. According to Quigley and Abu Shanub, 
three main components in treatment of SIBO: (1) 
Treatment of underlying disease and improvement of 
medical condition; (2) Eradication of excess bacterial 
JURZWK 5HVROYH QXWULWLRQDO GH¿FLHQFLHVZKLFK
related to SIBO.4
It is important to determine and treat the causes, 
symptoms and complications related to SIBO. If 
the cause is anatomical abnormality which potential 
to excess bacterial overgrowth, such as adhesion, 
intestinal obstruction, or strictur, then the treatment of 
6,%2LVWR¿[WKHDQDWRPLFDODEQRUPDOLW\%HVLGHWKDW
treatment of bacterial overgrowth including elimination 
of drugs that reduce intestinal motility or drugs that 
reduce gastric acidity. According to Vanderhoof et al, 
GLHWSODQDOVRKDYHVLJQL¿FDQWUROHLQ6,%2WUHDWPHQW,Q
many patients, it is important to eliminate lactose from 
dietary plan, to reduce other simple sugar molecules, 
to increase calory from fat, and to give medium chain 
triglycerol (MCT). In cases of decreased motility, such 
as chronic pseudo-obstruction, method to increase 
motility which used in United States are prokinetic 
drugs administration, such as metoclopramid and 
eritromisin. However while this method that used in 
Europe also by prucalopride administration, although 
this method have not been fully investigated as SIBO 
treatment. In condition where PPI is the cause of SIBO, 
OLIHVW\OHPRGL¿FDWLRQFDQEHVXVHGDVJDVWURHVRSKDJHDO
reflux disease (GERD) treatment or with reduce 
drugs that suppress stomach acid into the lowest dose 
or shortest duration may be useful in reduce SIBO 
symptoms.4 Despite efforts to treat the main causes 
SIBO has been done as mentioned before, but most 
patients still need antibiotics. Antibiotic administration 
must be done selectively in accordance to strain that 
caused SIBO. 
Goal of treatment with antibiotic administration is 
WRUHGXFHQRWHOLPLQDWHDOOQRUPDOÀRUD LQ LQWHVWLQH
therefore to improve symptoms. According to Singh 
and Toskes, ideally antibiotic selection can be based 
on bacterial sensitivity test to the antibiotics. However, 
antiobiotic administration should be based on culture 
test results in several subjects.4 There is not yet a 
general consensus on selection, dose, and duration 
of antiobiotic treatment. Chosen broad spectrum 
antibiotic which covered enteric aerob and anaerob 
antibiotic listed in the table below, which covered 
ciprofloxacin, norfloxacin, amoxicillin/clavulanat, 
metronidazole, cephalexin, and newest antibiotic, 
rifaxmin. According to Frissora and Cash, rifaximin 
start getting known because of its nonabsorbable 
characteristic, have less side effects, and only little 
evidence of bacterial resistance to this antibiotic. 
According to Vanderhoof et al, Yang et al, Rabenstein 
et al, dan Di S et al, rifaximin can be chosen antibiotic 
because of its clinical resistance less than other types 
of antibiotic.4
Table 2. Antibiotics for Treatment of SIBO4
Antibiotic choices for treatment of SIBO 
Rifaximin
&LSUSÀR[DFLQ
1RUÀR[DFLQ
Amoxicillin/Clavulanate 
Metronidazol + trimetophrim/sulfamethoxazole 
Metronidazole + Cephalexin 
Although management with antibiotic administration 
has been done, patients often require repeated antibiotic 
administrations and on some cases long term antibiotic 
use, such ad on extended small intestine divertikulosis. 
According to Lauritano et al, on some convensional 
cases, often repeated breath test needs to be done 
VXFK DV LI DEGRPLQDO SDLQ EORDWLQJ DQGÀDWXOHQFH
symptoms back. According to Pimentel et al, there is 
no clinical study which determine duration of treatment 
or management of recurrence SIBO, and current 
recomendation only based on clinical experience 
despite the success of treatment with rifaximin is 
reported.4
COMPLICATIONS OF SMALL INTESTINAL 
BACTERIAL OVERGROWTH (SIBO)
Complications of SIBO is varied from mild 
FRPSOLFDWLRQVVXFKDVGLDUUKHDDQGYLWDPLQGH¿FLHQFLHV
to severe ones, such as malabsorption and neuropathy 
FDXVHGE\IDWVROXEOHYLWDPLQVGH¿FLHQFLHV1XWULFDO
complications of SIBO is caused by maldigestion and 
malabsorption of foods in intestine.1 Malabsorption 
caused by microscopic structural damage in small 
intestine which reduce the absorptive ability of 
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microvilli. Fat malabsorption caused by deconjugation 
of bile salts by bacteria.1 Deconjugated bile salts is 
more absorbable in jejenum than in ileum, resulted 
in impairment micelle formation, fat malabsorption 
and fat-soluble vitamins deficiencies (vitamin A, 
D, E, K).1 But symptoms are rarely present, except 
on severe cases, such as xeropthalmia (vitamin 
$GH¿FLHQF\ RVWHRPDODFLD DQG WHWDQ\ FDXVHG E\
KLSRFDOFHPLDYLWDPLQ'GH¿FLHQF\SURWKURPELQWLPH
37HORQJDWLRQYLWDPLQ.GH¿FLHQF\QHXURSDWK\
retinopathy, and T cell function disorder. Carbohydrate 
malabsorpstion caused by premature breaking of sugar 
molecule by bacteria in conjugation with decreased 
activity of disaccharide enzyme caused by intestine 
brush border damage.1 Protein malabsorption caused by 
destruction process by bacteria, whereas enteropathy 
caused by protein loss due to intestine mucous damage. 
Most common complication of SIBO is vitamin B12 
GH¿FLHQF\3DWLHQWVZLWKÀRUDXVXVQRUPDOLQWHVWLQDO
ÀRUD GHSHQG RQ JDVWULF LQWULQVLF IDFWRUZKLFK ELQ
with B12 vitamin to allow the absroption process in 
LOHXP6,%2SDWLHQWVZLWKDWUR¿FJDVWULWLVDEVRUEVOHVV
vitamin B12 which bind to protein, compared with 
control. However, this condition can be improved 
with antibiotic administration. Level of folic acid can 
be normal, but more common to be elevated due to 
increased synthesis of folic acid by bacteria in small 
intestine.1 
CONCLUSION
6,%2GH¿QHGDVLQFUHDVLQJQXPEHURIEDFWHULDLQ
small intestine. Because of different etiologies of SIBO, 
often SIBO cases are misdiagnosed or underdiagnosed, 
since varied clinical manifestations and the treatment 
must be individualized with focus in the treatment of 
underlying disease.4 When antibiotic become main 
treatment, main attention is on the understanding 
of SIBO mechanism in patient became important to 
prevent relapse.4
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